Successful re-induction therapy for acute myelogenous leukemia with cytosine arabinoside and daunorubicin.
D000328:Adult; D003561:Cytarabine / Q000008:administration & dosage*; D003630:Daunorubicin / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012075:Remission, Spontaneous
D003561:Cytarabine; D003630:Daunorubicin